SELLAS Life Sciences Group, Inc.
SLS
$1.59
-$0.07-4.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 24.24% | 17.30% | 15.77% | 4.55% | -0.43% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.97% | -17.79% | -5.63% | 1.28% | 25.87% |
| Change in Net Operating Assets | -374.08% | -298.68% | -171.53% | -103.09% | -33.84% |
| Cash from Operations | -12.21% | -12.71% | -4.21% | -5.13% | -4.37% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | -20.00% | -22.22% |
| Cash from Investing | -- | -- | 100.00% | -20.00% | -22.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 45.29% | 109.26% | 152.26% | 53.11% | -29.86% |
| Repurchase of Common Stock | -6.67% | -6.67% | -6.90% | -6.90% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 45.37% | 109.54% | 152.47% | 53.18% | -30.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 281.92% | 177.81% | 198.18% | 64.64% | -156.86% |